Alaide Morcavallo
Senior Scientist, Research, Bioscience & Oncology AstraZeneca
Seminars
Thursday 3rd December 2026
Insight Exchange – Building an End-to-End Development Strategy That Delivers Better Decisions
3:20 pm
- Where do development programmes most commonly break down between discovery, translational, clinical, and external partners?
- How early should CROs, translational scientists, and pharmacology teams be involved in model selection decisions?
- What distinguishes a strategic partner from a service provider when generating decision-grade data?
- How can organisations balance speed, cost, scientific rigour, and translational confidence throughout development?
- Audience Q&As
Thursday 3rd December 2026
Evidence – Moving Beyond Data Generation to Strategic CRO Partnerships in Tumour Model Development
3:00 pm
- Evaluating CROs not only on execution, but on their ability to provide scientific insight and study design support
- Avoiding cost driven decisions that compromise data quality and long term development success
- Building effective collaborations that strengthen decision making and improve translational confidence
